https://pipelinereview.com/citius-pharmaceuticals-inc-submits-biologics-license-application-to-the-u-s-food-and-drug-administration-for-denileukin-diftitox-for-the-treatment-of-patients-with-persistent-or-recurrent-cutaneous-t/